Clinical Trials on AMS-H-03

Total 1618 results

Guangzhou Institute of Respiratory Disease

Not yet recruiting

Hydrogen-Oxygen Generator With Nebulizer for Adjuvant Treatment of Novel Coronavirus Disease 2019 (COVID-19)

Covid19 | Hydrogen-oxygen Gas | AMS-H-03

China
Shanghai Zhongshan Hospital

Recruiting

Hydrogen-Oxygen Generator With Nebulizer for Rehabilitation Treatment of COVID-19

COVID-19 | Hydrogen-oxygen Gas | AMS-H-03

China
Ruijin Hospital

Active, not recruiting

Hydrogen-Oxygen Generator With Nebulizer for Adjuvant Treatment of COVID-19 Positive Patients

Covid19 | Hydrogen-oxygen Gas | AMS-H-03

China
Guangzhou Institute of Respiratory Disease

Unknown

Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19)

Covid19 | Hydrogen-oxygen Gas | AMS-H-03

China
Cosmo Technologies Ltd

Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Advanced Refractory Solid Tumors | Subjects Considered Likely to Respond to CB-03-10

United States
Hafiz Muhammad Asif

Completed

Quadruple and Phytomedicine-based Therapies in H. Pylori Infection

Helicobacter Pylori [H. Pylori] as the Cause of Diseases

Pakistan
Akdeniz University
The Scientific and Technological Research Council of Turkey

Completed

The Effect of an Avatar-Based Education Program on Shunt Complications and Parents' Knowledge and Care Skills

Developing the ABEP-H | Determining the Effect of ABEP-H

Turkey
OneBlood, Inc.
OrSense, Ltd.

Completed

NBM-200 Clinical Study in Blood Donation Setting

Hemoglobin H

United States
Ramathibodi Hospital

Completed

Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori

H Pylori Eradication

Thailand
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bristol-Myers Squibb; National Cancer Institute (NCI)

Recruiting

Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor

Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy | MSI-H Tumors

United States
University of Latvia
National Institute of Public Health, Slovenia; Iuliu Hatieganu University of... and other collaborators

Recruiting

H. Pylori Screen-and-treat Study in a Population of Young Adults

Gastric Cancer | H Pylori Infection | H Pylori Eradication | H-pylori

Poland, Croatia, Ireland, Latvia, Romania, Slovenia
Assistance Publique - Hôpitaux de Paris

Unknown

Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection (Hepysé)

H Pylori Eradication | H Pylori Infection Eradication | Antibiotics Therapeutic Strategies

France
University Hospital, Clermont-Ferrand
Hospices Civils de Lyon; Centre Hospitalier Universitaire de Saint Etienne; University... and other collaborators

Completed

Treatment Strategy in Patients With High-risk of Postextubation Distress in ICU Based on a Lung Ultrasound Score Versus Standard Strategy (WIN IN WEAN)

Adult Patients Ventilated More Than 48 h

France
Soonchunhyang University Hospital

Completed

Bismuth for PCAB-based H. Pylori Eradication

H. Pylori Infection

Korea, Republic of
ARJ Medical, Inc.

Completed

ARJ C13 Urea Breath Test System

H. Pylori Infection

United States
Hamamatsu University

Unknown

Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori (EHR)

H. Pylori Infection

Japan
National Taiwan University Hospital

Completed

Efficacy of 10-day and 14-day Sequential Therapy Versus Triple Therapy on the Eradication of Helicobacter Pylori

H. Pylori Infection

Taiwan
National Taiwan University Hospital

Unknown

Genotypic Resistance Guided Therapy for Refractory H. Pylori Infection

H Pylori Infection

Taiwan
Changhai Hospital

Recruiting

Oral Helicobacter Pylori Eradication

H. Pylori Infection

China
Soonchunhyang University Hospital

Completed

H. Pylori Treatment Between Modified Quadruple Regimen and Tailored Therapy

H. Pylori Infection

Korea, Republic of
Assiut University

Completed

Helicobacter Pylori and it's Hematological Impact

H Pylori Infection
Takeda

Completed

Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori

H. Pylori Infection

Japan
The University of Texas Health Science Center,...

Unknown

H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study

H. Pylori Infection

United States
Hamamatsu University

Completed

Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori

H. Pylori Infection

Japan
Jiangsu Province Centers for Disease Control and...
Third Military Medical University; National Institutes for Food and Drug Control... and other collaborators

Completed

A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children

H. Pylori Infection

China
Yonsei University

Withdrawn

A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide

H. Pylori Infection

Korea, Republic of
Assiut University

Not yet recruiting

Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy

H Pylori Infection

Egypt
Assiut University

Unknown

Screening of Helicobacter Pylori in Children of Positive Infected Mothers

H Pylori Infection
Zhongshan Hospital (Xiamen), Fudan University

Not yet recruiting

Effect of Intestinal Microecology After HDDT Combined With Probiotics for Helicobacter Pylori Eradication

H Pylori Infection Eradication
National Taiwan University Hospital

Unknown

The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships

Peptic Ulcer With H. Pylori Infection | Gastritis With H. Pylori Infection

Taiwan
Shanghai Henlius Biotech

Recruiting

A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy

MSI-H Solid Malignant Tumor

China
BeiGene

Recruiting

Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors

MSI-H/dMMR Solid Tumors

China
Akeso
Akeso Pharmaceuticals, Inc.

Terminated

A Study of AK104 in Subjects With Locally Advanced Unresectable or Metastatic MSI-H/dMMR Solid Tumors

MSI-H/dMMR Solid Tumor

China
Shaheed Zulfiqar Ali Bhutto Medical University

Recruiting

Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children (CETR)

H Pylori Gastritis

Pakistan
Chinese University of Hong Kong

Unknown

Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study (vDHp)

H. Pylori Infection

Hong Kong
Servier Bio-Innovation LLC
Merck Sharp & Dohme LLC; Institut de Recherches Internationales Servier

Not yet recruiting

A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.

MSI-H/dMMR Gastroesophageal-junction Cancer | MSI-H/dMMR Gastric Cancer
ImmuneOncia Therapeutics Inc.

Not yet recruiting

A Study of Phase2, IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor (TMB-H)

TMB-H | Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors
Peking University Cancer Hospital & Institute

Recruiting

Registry Study in MSI/dMMR Solid Tumors

Solid Tumor | MSI-H | DMMR Cancer

China
Lama Medical Care s.r.o.
BioGaia AB

Unknown

Supplementation With L. Reuteri in H. Pylori Infected Adults

Dyspepsia | H. Pylori Infection

Slovakia
University Medical Center Groningen

Recruiting

Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors (TIRACAN)

Melanoma | Head and Neck Neoplasms | MSI-H Cancer

Netherlands
Merna Mawgoud Zaki Bechit

Not yet recruiting

Correlation Between H.Pylori Colonization and Gastritis

Gastritis H Pylori
Soonchunhyang University Hospital

Completed

Magnifying NBI Endoscopy for Gastric Condition

Gastritis H Pylori

Korea, Republic of
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor

MSI-H or dMMR Advanced Solid Tumors

China
Shanghai Zhongshan Hospital

Recruiting

Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection

H. Pylori Infection

China
National Taiwan University Hospital

Recruiting

Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection

H. Pylori Infection

Taiwan
Javier P. Gisbert

Recruiting

European Registry on the Management of Helicobacter Pylori Infection

H. Pylori Infection

Switzerland, France, Serbia, Latvia, Estonia, Austria, Belgium, Bulgaria, Croatia, Czechia, Denmark, Finland, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovenia and more
University of Rostock

Completed

Influence of Perioperative Fluid Therapy on Hemoglobin and Methemoglobin Levels

Fluid Overload | Perioperative/Postoperative Complications | Hemoglobin H

Germany
National Taiwan University Hospital

Completed

The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study

H. Pylori Infection

Taiwan
Biotronik AG

Completed

PROGRESS-AMS 1.0 Clinical Long Term Follow-Up

Long Term Safety of the AMS 1.0

Switzerland, Germany, Australia, Belgium, Netherlands
National Cheng-Kung University Hospital

Recruiting

Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.

Carcinogenesis | H. Pylori Infection

Taiwan

Clinical Trials on AMS-H-03

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations